Inventing the Future 2012 A Seminar for Inventors, Entrepreneurs, Researchers, Students and Professionals.Presented at Inventing the Future 2012, Saturday, April 21, 2012
Clough Commons Auditoriums, Georgia Institute of Technology.Dr. Harold Shlevin currently leads Georgia Institute of Technology’s Advanced Technology Development Center (ATDC) as manager of bioscience commercialization efforts. He serves as a startup catalyst and Executive-In-Residence evaluating new technologies, advising faculty and others on product development, licensing and business development, guiding new and emerging bioscience companies as a consultant and advisor, determining the commercial potential of technologies, and oversees and advises client companies in a bioscience incubator facility. He also serves as a consultant and advisor to established bioscience companies. Dr. Shlevin is a 25-year bioscience-industry executive with broad senior management experience in development and commercialization of medical devices, pharmaceuticals, diagnostics and vaccines; he founded two startup companies. He has unusually diverse healthcare business-related and global management experiences in pharmaceuticals, medical devices, diagnostics and vaccines. He has a particularly strong background in business development including strategic planning, licensing, academic/industrial relationships, and mergers & acquisitions. Dr Shlevin earned a BA degree from Boston University, a MS and PhD degrees in physiology from the University of Rochester Medical School and completed post-doctoral training in pharmacology at Mayo Clinic where he subsequently served as Assistant Professor of Pharmacology & Physiology. He is a member of scientific and business societies including IEEE, Licensing Executives Society, Southeast Medical Device Association, Am. Physiological Society, Am. Society of Pharmacology & Experimental Therapeutics, and an inventor on several issued and pending patents. Dr. Shlevin currently serves on the Board of Directors of Cardiome Pharma Corp. (NASDAQ:CRME) and NeurOp, Inc. and as an advisor to Clearside Biomedical, Inc. Further information is available at http://www.linkedin.com/in/hshlevin
